Review: Etanercept (25 mg subcutaneously twice weekly) reduces symptoms and disease activity in rheumatoid arthritis
- Biological response modifiers in the management of rheumatoid arthritis. Louie, Stan G.; Park, Brian; Yoon, Hannah // American Journal of Health-System Pharmacy;2/15/2003, Vol. 60 Issue 4, p346
Presents a review on the management of rheumatoid arthritis (RA) with biological response modifiers. Molecular pathogenesis of RA; Role of interleukin-1 Ra in RA; Treatment of RA; Modulation of inflammatory cytokines; Use of anakinra in patients with RA.
- Lithothamnion muelleri Treatment Ameliorates Inflammatory and Hypernociceptive Responses in Antigen-Induced Arthritis in Mice. Costa, Vivian V.; Amaral, Flavio A.; Coelho, Fernanda M.; Queiroz-Junior, Celso M.; Malagoli, Bruna G.; Gomes, Jose Hugo S.; Lopes, Fernando; Silveira, Kátia D.; Sachs, Daniela; Fagundes, Caio T.; Tavares, Lívia D.; Pinho, Vanessa; Silva, Tarcilia A.; Teixeira, Mauro M.; Braga, Fernão C.; Souza, Danielle G. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1
Rheumatoid Arthritis (RA) is a chronic disease characterized by persistent inflammation and pain. Alternative therapies to reduce these symptoms are needed. Marine algae are valuable sources of diverse bioactive compounds. Lithothamnion muelleri (Hapalidiaceae) is a marine algae with...
- Growing Concerns. Miles, Otesa Middleton // Arthritis Today;Nov/Dec2012, Vol. 26 Issue 6, p66
The article offers information on ways to tell apart serious conditions such as juvenile arthritis (JA) from simple growing pains in young children complaining about pain.
- Effects of anxiety sensitivity and expectations on the modulation of the startle eyeblink response during a caffeine challenge. Benke, Christoph; Blumenthal, Terry; Modeß, Christiane; Hamm, Alfons; Pané-Farré, Christiane // Psychopharmacology;Sep2015, Vol. 232 Issue 18, p3403
Rationale: The way in which the tendency to fear somatic arousal sensations (anxiety sensitivity), in interaction with the created expectations regarding arousal induction, might affect defensive responding to a symptom provocation challenge is not yet understood. Objectives: The present study...
- Risk of Cancer in RA Patients Treated with Disease-Modifying Drugs. Kuritzky, Louis // Neurology Alert;Dec2012 Clinical Briefs In Primary Care, p24
The article summarizes a study which shows that the short-term use of biologic response modifiers (BRM) in treating rheumatoid arthiritis (RA) did not increase the risk of cancer, contrary to reports in the Adverse Event Reporting System database.
- Risk of Cancer in RA Patients Treated with Disease-Modifying Drugs. Kuritzky, Louis // Internal Medicine Alert;11/29/2012, Vol. 34 Issue 22, p176
The article focuses on the risk of cancer by treatment of Rheumatoid Arthritis using biological response modifier drugs.
- BIOLOGIC RESPONSE MODIFIERS. // Arthritis Today;Jan/Feb2002, Vol. 16 Issue 1, p40
Presents a list of biologic response modifiers used in the treatment of rheumatoid arthritis. Therapeutic benefits of biologic response modifiers; Approval of the biologic agent Anakinra in 2001; List of drugs and their possible side effects.
- Costimulation modulators target RA, transplant rejection. Posey, L. Michael // Pharmacy Today;Nov2005, Vol. 11 Issue 11, p10
The article reports on costimulation modulators abatacept and belatacept, which are useful in the treatment of rheumatoid arthritis (RA). A study involving 339 patients, which was published in the August 2005 issue of the Arthritis & Rheumatism, showed that abatacept improved clinical symptoms...
- â€˜Iâ€™m hurting, I want to kill myselfâ€™: rheumatoid arthritis flare is more than a high joint countâ€”an international patient perspective on flare where medical help is sought. Hewlett, Sarah; Sanderson, Tessa; May, James; Alten, Rieke; Bingham, Clifton O.; Cross, Marita; March, Lyn; Pohl, Christof; Woodworth, Thasia; Bartlett, Susan J. // Rheumatology;Jan2012, Vol. 51 Issue 1, p69
Objective. People with RA have episodes of worsening disease activity (flares) that prompt them to seek clinical review or medication change. This study explored patientsâ€™ perspectives of flare that prompts them to seek medication review.Methods. Fourteen focus groups across five...